7:55am ET
Health and Healthcare
Even More Biopharma Catalysts Coming Through the End of March
Here, 24/7 Wall St. has included a calendar of some of the biggest companies expecting clinical trial and FDA updates for the rest of March.
Companies
Arena Pharmaceuticals, Inc.
$99.99
â–² $0.00 (+0.00%) today
Markets open · 11:08am ET
ARNA Coverage
Page 211:40am ET
Health and Healthcare
Credit Suisse Outlines Top Biotech M&A Targets and Catalyst Stocks for 2018
Credit Suisse sees tax reform sparking a wave of mergers in the emerging pharmaceuticals space, which could produce sector outperformance. The firm is cautiously optimistic on this front.
9:05am ET
Investing
Top Analyst Upgrades and Downgrades: BofA, Honeywell, IBM, Lululemon, Oracle, United Tech, Wells Fargo and Many More
The top analyst upgrades, downgrades and other research calls from Wednesday include Bank of America, Honeywell, IBM, Lululemon Athletica, Oracle, United Technologies and Wells Fargo.
4:10pm ET
Investing
Did You Just Miss the Launch of the US-Listed Marijuana ETF?
Ahead of the California legalization efforts, a U.S.-listed marijuana-focused exchange traded fund has quietly begun trading.
10:50am ET
Health and Healthcare
Why Arena Pharmaceuticals Is Knocking It Out of the Park
Shares of Arena Pharmaceuticals saw an incredible gain early Tuesday after the company reported positive results from its mid-stage trial in patients with pulmonary arterial hypertension.
Chris Lange 9:05am ET
Investing
Top Analyst Upgrades and Downgrades: Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess, Western Digital and More
The top analyst upgrades, downgrades and other research calls from Tuesday include Alibaba, BHP Billiton, Cintas, Monsanto, Schlumberger, Shopify, Hess and Western Digital.
9:10am ET
Investing
Top Analyst Upgrades and Downgrades: Alphabet, Enterprise Products, GrubHub, Mattel, Ryanair, Splunk and Many More
The top analyst upgrades, downgrades and other research calls include Alphabet, Enterprise Products, GrubHub, Mattel, Ryanair and Splunk.
9:20am ET
Investing
Huge Transport Trade Highlights Insider Buying: CSX, GE, Mattel, IFF and More
The the man in charge of one of the nation's biggest railroads was among insiders making notable purchases of shares this past week.
4:04pm ET
Investing
Valeant, Arena Pharmaceuticals in Tuesday’s 52-Week Low Club
Valeant, Arena, Teva, and Frontier Communications all posted new 52-week lows on Tuesday.
10:35am ET
Health and Healthcare
Arena Pharmaceuticals Sinks After Announcing Secondary Offering
Arena Pharmaceuticals saw its shares drop sharply on Tuesday after the company announced a secondary offering of 60 million shares of its common stock.
Chris Lange 12:10pm ET
Health and Healthcare
Wednesday’s Biggest Biopharma Movers
The broad markets are inching forward on Wednesday after hitting new highs in what has been known as the Trump rally. Although the SPDR S&P Biotech ETF (NYSEMKT: XBI) is up about…
8:05am ET
Companies and Brands
The 10 Largest Marijuana Companies
The impact of cannabis products is expected to grow to an estimated $44 billion by 2020. Which companies will be earning those billions?
10:15am ET
Health and Healthcare
Top 6 BioPharma Movers of the Week
These biotech companies stood out from the rest with incredible gains or losses over the course of the past week.
1:35pm ET
Health and Healthcare
Arena Pharma Soars on FDA Approval
Arena Pharmaceuticals saw its shares jump in Monday’s session on news of an U.S. Food and Drug Administration (FDA) approval.
Chris Lange 8:20am ET
Investing
5 Stocks That Should See Huge Buying on Russell Month-End Index Changes
A new research note from the quantitative strategies team at Jefferies highlights the top buys and sells for the Russell 1000 and Russell 2000. These five companies will see the most shares…